Shani Waninger

Senior Business Development Director

Shani has over 20 years’ experience in drug discovery and development with
expertise in therapeutic intervention for neurodegenerative and neuropsychiatric disorders and development of CNS biomarkers. Shani earned a Ph.D. in biochemistry at Johns Hopkins University and subsequently completed postdoctoral training at UCLA. Through multiple professional roles and publications, she has established a track record for building collaborative relationships with sponsors, academic investigators, clinicians and KOLs to
advance precision medicine in neuroscience. Scientific areas of interest include Alzheimer’s, Parkinson’s and Huntington’s disease as well as major depressive disorder and PTSD. Shani currently plays a key role in advancement and implementation of translational biomarkers in preclinical and clinical stage CNS
studies at Ulysses Neuroscience.